p53 -: A natural cancer killer:: Structural insights and therapeutic concepts

被引:85
作者
Roemer, Lin
Klein, Christian
Dehner, Alexander
Kessler, Horst
Buchner, Johannes
机构
[1] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany
[2] Roche Diagnost GmbH, Pharma Res, Mol Biol, D-82372 Penzberg, Germany
[3] Tripos GmbH, D-81829 Munich, Germany
关键词
apoptosis; molecular chaperones; protein folding; protein stability; tumor therapy;
D O I
10.1002/anie.200600611
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Every single day, the DNA of each cell in the human body is mutated thousands of times, even in absence of oncogenes or extreme radiation. Many of these mutations could lead to cancer and, finally, death. To fight this, multicellular organisms have evolved an efficient control system with the tumor-suppressor protein p53 as the central element. An intact p53 network ensures that DNA damage is detected early on. The importance of p53 for preventing cancer is highlighted by the fact that p53 is inactivated in more than 50 % of all human tumors. Thus, for good reason, p53 is one of the most intensively studied proteins. Despite the great effort that has been made to characterize this protein, the complex function and the structural properties of p53 are still only partially known. This review highlights basic concepts and recent progress in understanding the structure and regulation of p53, focusing on emerging new mechanistic and therapeutic concepts. © 2006 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:6440 / 6460
页数:21
相关论文
共 323 条
[31]   Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation [J].
Brooks, CL ;
Gu, W .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :164-171
[32]   Correcting temperature-sensitive protein folding defects [J].
Brown, CR ;
HongBrown, LQ ;
Welch, WJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1432-1444
[33]   Introduction: the cellular protein folding machinery [J].
Buchner, J .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (10) :1587-1588
[34]   Interaction of epothilone analogs with the paclitaxel binding site:: Relationship between binding affinity, microtubule stabilization, and cytotoxicity [J].
Buey, RM ;
Díaz, JF ;
Andreu, JM ;
O'Brate, A ;
Giannakakou, P ;
Nicolaou, KC ;
Sasmal, PK ;
Ritzén, A ;
Namoto, K .
CHEMISTRY & BIOLOGY, 2004, 11 (02) :225-236
[35]   The Hsp70 and Hsp60 chaperone machines [J].
Bukau, B ;
Horwich, AL .
CELL, 1998, 92 (03) :351-366
[36]   Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy [J].
Bullock, AN ;
Henckel, J ;
Fersht, AR .
ONCOGENE, 2000, 19 (10) :1245-1256
[37]   Rescuing the function of mutant p53 [J].
Bullock, AN ;
Fersht, A .
NATURE REVIEWS CANCER, 2001, 1 (01) :68-76
[38]   Thermodynamic stability of wild-type and mutant p53 core domain [J].
Bullock, AN ;
Henckel, J ;
DeDecker, BS ;
Johnson, CM ;
Nikolova, PV ;
Proctor, MR ;
Lane, DP ;
Fersht, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14338-14342
[39]   Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs [J].
Bykov, VJN ;
Issaeva, N ;
Zache, N ;
Shilov, A ;
Hultcrantz, M ;
Bergman, J ;
Selivanova, G ;
Wiman, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (34) :30384-30391
[40]   PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis [J].
Bykov, VJN ;
Zache, N ;
Stridh, H ;
Westman, J ;
Bergman, J ;
Selivanova, G ;
Wiman, KG .
ONCOGENE, 2005, 24 (21) :3484-3491